Stocks / ACAD / Gross Profit

ACADIA Pharmaceuticals Inc. Gross Profit 2009–2025

ACADIA Pharmaceuticals Inc. reported $982.51M of gross profit for fiscal 2025. That was 12.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +127.7%.

Latest filed value
$982.51M
One-year change
+12.2%
Change since 2020
+127.7%
Latest period end
2025
ACADIA Pharmaceuticals Inc. Gross Profit history from 2016 to 2025FY 2016: 14252000FY 2017: 115824000FY 2018: 211430000FY 2019: 327732000FY 2020: 431544000FY 2021: 473302000FY 2022: 507068000FY 2023: 684799000FY 2024: 875956000FY 2025: 982507000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025$982.51M91.7%+12.2%
FY 2024$875.96M91.5%+27.9%
FY 2023$684.80M94.3%+35.1%
FY 2022$507.07M98.0%+7.1%
FY 2021$473.30M97.8%+9.7%
FY 2020$431.54M97.7%+31.7%
FY 2019$327.73M96.7%+55.0%
FY 2018$211.43M94.5%+82.5%
FY 2017$115.82M92.7%+712.7%
FY 2016$14.25M82.2%
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010
FY 2009

Source: ACADIA Pharmaceuticals Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ACAD 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

ACADIA Pharmaceuticals Inc. reported $982.51M of gross profit for fiscal 2025. That was 12.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +127.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for ACADIA Pharmaceuticals Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

ACADIA Pharmaceuticals Inc. — frequently asked questions

What is ACADIA Pharmaceuticals Inc.'s gross profit?

ACADIA Pharmaceuticals Inc. (ACAD) reported gross profit of $982.51M for fiscal year 2025, per its SEC filings.

How has ACADIA Pharmaceuticals Inc.'s gross profit changed over time?

Between fiscal 2009 and 2025, ACAD's gross profit grew at roughly 30.3% per year (compound annual rate), from $14.25M to $982.51M.

Where does this data come from?

Figures are computed from ACADIA Pharmaceuticals Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More ACAD financial history

Full ACAD fundamentals page → · Analyze gross profit with a free tool → · All 1,500+ companies →